Literature DB >> 26143129

Treatment of selected syringomyelias with syringo-pleural shunt: the experience with a consecutive 26 cases.

Tao Fan1, XinGang Zhao2, HaiJun Zhao3, Cong Liang2, YinQian Wang2, QiFei Gai2, Fangyi Zhang4.   

Abstract

OF BACKGROUND DATA: It is well established that syringomyelia can cause neurological symptoms and deficit by accumulation of fluid within syrinx cavities that lead to internal compression within the spinal cord. When other intervention treating the underlying etiology failed to yield any improvement, the next option would be a procedure to divert the fluid from the syrinx cavity, such as syringo-subarachnoid, syringo-peritoneal or syringo-pleural shunting. The indications and long term efficacy of these direct shunting procedures are still questionable and controversial.
OBJECTIVE: To investigate the clinical indication, outcome and complication of syringe-pleural shunt (SPS) as an alternative for treatment of syringomyelia. STUDY
DESIGN: We reported a retrospective 26 cases of syringomyelia were found to have indication for a diversion procedure. SPS was offered. Patients' symptoms, mJOA score, and MRI were collected to evaluate the change of the syringomyelia and prognosis of the patients. 2-tailed wilcoxon signed-rank test was used to perform the statistical analysis of the mJOA scores.
METHODS: All 26 patients underwent SPS. The clinical information was collected, the mean follow-up time was 27.4 months, 2-tailed wilcoxon signed-rank test was used to perform the statistical analysis of the mJOA scores. The key surgical technique, outcome and complications of SPS were reported in detail.
RESULTS: No mortality and severe complications occurred. Postoperative MRIs revealed near-complete resolution of syrinx in 14 patients, significant shrinkage of syrinx in 10 patients, no obvious reduction or unchanged in remaining 2 patient. Postoperatively, the symptoms improved in 24 cases (92.3%). Statistical analysis of the mJOA scores showed a statistical significance (P<0.001) between the preoperative group and the 2-week postoperative group. No further significant improvement between 2 weeks to the final follow up at 27 months.
CONCLUSION: Collapse or remarkable shrinkage of the syrinx by SPS could ameliorate or at least stabilize the symptoms for the patient. We recommend small laminectomy and a less than 3mm myelotomy either at PML or DREZ. The SPS procedure can be an effective and relatively long-lived treatment for the idiopathic syringomyelia and those that failed other options.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CSF homeostasis; Cerebrospinal fluid homeostasis; Myelotomy; Syringomyelia; Syringopleural shunting

Mesh:

Year:  2015        PMID: 26143129     DOI: 10.1016/j.clineuro.2015.06.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Recurrent symptomatic pleural effusion from a syringopleural shunt.

Authors:  Crystal T Ajja; Tiffany F Chang; Eric Ayers
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-01-22

2.  Surgical management of Chiari I malformation based on different cerebrospinal fluid flow patterns at the cranial-vertebral junction.

Authors:  Tao Fan; HaiJun Zhao; XinGang Zhao; Cong Liang; YinQian Wang; QiFei Gai
Journal:  Neurosurg Rev       Date:  2017-02-09       Impact factor: 3.042

3.  Direct syrinx drainage in patients with Chiari I malformation.

Authors:  Jehuda Soleman; Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2019-06-01       Impact factor: 1.475

4.  The Management of Idiopathic and Refractory Syringomyelia.

Authors:  Pasquale Gallo; Chandrasekaran Kaliaperumal
Journal:  Adv Tech Stand Neurosurg       Date:  2022

5.  Treatment of Posttubercular Syringomyelia Not Responsive to Antitubercular Therapy: Case Report and Review of Literature.

Authors:  Giuseppe Canova; Alessandro Boaro; Enrico Giordan; Pierluigi Longatti
Journal:  J Neurol Surg Rep       Date:  2017-04

6.  A simple technique for thoracoscopic assisted placement of the distal limb of syringopleural shunts.

Authors:  Hugo Jr Bonatti; Khalid H Kurtom
Journal:  Respir Med Case Rep       Date:  2018-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.